Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, is investing in a laboratory expansion at its site in Tredegar, Wales, UK. The Tredegar facility is PCI’s center of excellence for development and...

Thermo Fisher Scientific plans to invest $35 million in a pharmaceutical services supply-chain facility in Rheinfelden (Baden) Germany. The new facility will increase capacity for cold and ambient clinical trial materials in support of clinical...

MedPharm, a Guildford, England-headquartered provider of formulation and development services for topical and transdermal products, has invested $75 million on automated instrumentation for its US facilities based in Durham, North Carolina. The...

Charles River Laboratories, a Wilmington, Massachusetts-headquartered contract research organization (CRO), has added a new, 73,000-square-foot facility in Wayne, Pennsylvania to expand its biologics testing services. Charles River announced...

Selexis SA, a Geneva, Switzerland-based provider of mammalian cell-line generation technology, has agreed to license its mammalian cell line-based protein expression platform (SUREtechnology) to Compugen, a Richmond Hill, Ontario,...

AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization, is adding a 2,000-liter single-use bioreactor (SUB) to its Berkeley, California facility. AGC’s Berkeley facility offers cell-culture...

ST Pharm, a Seoul, South Korea-based provider of nucleic acid manufacturing and development services, has announced an expansion of oligonucleotide manufacturing capacity. The company is constructing a new facility at its Banwol site. The...

Draper, a Spiceland, Indiana-headquartered research and development company, has developed a microfluidic transduction device (MTD) for companies to manufacture T-cell therapies with less viral vectors, the delivery vehicle of genomic materials...

Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has signed a licensing agreement with Altus Formulation, a Quebec, Canada-headquartered drug formulation and development company, to access drug-delivery...

Pall Corporation, a provider of filtration, separation, and purification products and services, has opened its expanded facility in Hoegaarden, Belgium after eight months of construction. The Hoegaarden facility expansion includes 2,000...

Catalent Pharma Solutions has completed a two-year, $4.6-million expansion at clinical-supply facility in Singapore.   The new expansion provides additional GMP space for secondary packaging, has doubled ambient storage, and quadrupled...

Almac Group, a Craigavon, UK-based contract development and manufacturing organization, has opened a 95,000-square-foot cold-storage facility at its global headquarters in Northern Ireland. The facility represents the completion of a £20 million...

STA Pharmaceutical Co., a WuXi AppTec subsidiary focused on small-molecule pharmaceutical development and manufacturing, and Regulus Therapeutics, a San Diego, California-headquartered biopharmaceutical company focused on microRNA-targeting drugs,...